Effective and Affordable Flu Vaccines for the World

Project Information

INDIGO

Grant agreement ID: 874653

DOI

10.3030/874653

EC signature date 13 December 2019

Start date 1 April 2020

End date 31 March 2026

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 16 000 968,00

EU contribution

€ 9 975 979,00

Coordinated by

STICHTING AMSTERDAM UMC
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (4)

Report on status of posting results in the study registry TETRA-LITE Phase I (EU)

Report on the status of the results posting including timelines when final posting of results is scheduled after end of funding period of Phase I trial TETRA-LITE (EU).

Publication LVA and MDPA adjuvants on human PBMCs

Publication LVA and MDPA adjuvants on human PBMCs and DCs

Report/Publication protective immunity TETRA-LITE in ferrets

ReportPublication protective immunity TETRALITE in ferrets

Report/Publication mode of action LVA for CTA

ReportPublication mode of action LVA for CTA

Websites, patent fillings, videos etc. (1)

Website, Facebook, etc.

Website Facebook etc

Publications

Peer reviewed articles (4)

Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cells

Author(s): Srinivasa Reddy Bonam, Peter Paul Platenburg and Jagadeesh Bayry
Published in: Frontiers Immunology, Issue 9 January 2023, 2023, ISSN 1664-3224
Publisher: Frontiers in immunology

Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo

Author(s): Sneha Raj, Preeti Vishwakarma, Shikha Saxena, Varun Kumar, Ritika Khatri, Amit Kumar, Mrityunjay Singh, Surbhi Mishra, Shailendra Asthana, Shubbir Ahmed, Sweety Samal
Published in: Vaccines, Issue 11, 2023, Page(s) 780, ISSN 2076-393X
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines11040780

Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study

Author(s): Valentino D’Onofrio, Sharon Porrez, Bart Jacobs, Azhar Alhatemi, Fien De Boever, Gwenn Waerlop, Els Michels, Francesca Vanni, Alessandro Manenti, Geert Leroux-Roels, Peter Paul Platenburg, Luuk Hilgers, Isabel Leroux-Roels
Published in: Vaccines, Issue 12, 2024, Page(s) 1036, ISSN 2076-393X
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines12091036

Carbohydrate fatty acid monosulphate ester is a potent adjuvant for low-dose seasonal influenza vaccines

Author(s): Peter Paul L.I. Platenburg, Frantz Deschamps, Jennifer Jung, Clément Leonard, Séverine Rusconi, S.B. Mohan Kumar, S.M. Sulaiman, Leon de Waal, Luuk A. Th. Hilgers
Published in: Vaccine, Issue 41, 2023, Page(s) 6980-6990, ISSN 0264-410X
Publisher: Elsevier BV
DOI: 10.1016/j.vaccine.2023.10.017